| Not Yet Recruiting | A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PC Hypercholesterolemia | Phase 2 / Phase 3 | 2026-03-01 |
| Not Yet Recruiting | A Study of SHR-1918 In Participants With Hypertriglyceridemia Hypertriglyceridemia | Phase 3 | 2026-02-01 |
| Recruiting | A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia Hyperlipidemia | Phase 3 | 2026-01-13 |
| Not Yet Recruiting | A Phase I Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multip Obesity, Overweight | Phase 1 | 2025-12-01 |
| Not Yet Recruiting | A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure Heart Failure | Phase 1 | 2025-11-01 |
| Not Yet Recruiting | Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolem Homozygous Familial Hypercholesterolemia | Phase 2 | 2025-08-01 |
| Not Yet Recruiting | Safety, Tolerability and Pharmacokinetic Study of HRS-8829 Acute Ischemia Stroke | Phase 1 | 2025-07-01 |
| Not Yet Recruiting | A Single Ascending Dose of HRS-4029 in Healthy Subjects Acute Ischemic Stroke | Phase 1 | 2025-04-01 |
| Completed | A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Prevention of Arterial and Venous Thrombosis | Phase 3 | 2025-03-16 |
| Completed | A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy a Homozygous Familial Hypercholesterolemia | Phase 3 | 2025-02-13 |
| Recruiting | The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction Severe Cerebral Edema Following Large Hemispheric Infarction | Phase 2 / Phase 3 | 2025-02-07 |
| Not Yet Recruiting | A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects Heart Failure | Phase 1 | 2024-11-01 |
| Completed | Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia Hyperlipidemia | Phase 2 | 2024-07-02 |
| Unknown | Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Pat Atrial Fibrillation | Phase 1 | 2024-03-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboem Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery | Phase 2 | 2024-02-16 |
| Completed | Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia Homozygous Familial Hypercholesterolemia | Phase 2 | 2023-12-22 |
| Completed | Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic Hyperlipidemic | Phase 2 | 2023-11-24 |
| Completed | SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty Prevention of Venous Thromboembolism After Knee Arthroplasty | Phase 2 | 2023-04-12 |
| Completed | A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction Brain Swelling, Large Hemispheric Infarction | Phase 2 | 2023-04-07 |
| Unknown | Safety and Tolerability of SHR-1918 in Healthy Subjects Hyperlipemia | Phase 1 | 2022-06-27 |
| Unknown | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Heal Prevention of Arterial and Venous Thrombosis | Phase 1 | 2022-05-24 |
| Terminated | Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmac Diabetes | Phase 1 | 2022-05-18 |